Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Оно Фармасьютикал Ко., Лтд.filedCriticalОно Фармасьютикал Ко., Лтд.
Priority to UAA200604787ApriorityCriticalpatent/UA84578C2/en
Publication of UA84578C2publicationCriticalpatent/UA84578C2/en
A drug containing from about one to five equivalents of a basic metal ion supplied from a metal salt of a weak acid or a metal hydroxide per equivalent of (2R)-2-propyloctaonic acid or its salt, which is useful in treating neurodegenerative diseases, optionally together with other additives. The above-described drug is a high-concentration drug, which has a pH value suitable for intravenous administration, is highly tolerant to pH changes and remains transparent after diluted to prepare an infusion, thereby enabling the preparation of an injection and so on with the use of an arbitrary solvent and/or a diluting fluid.
UAA200604787A2004-10-012004-10-01Drug containing (2r)-2-propyloctaonic acid as an active ingredient
UA84578C2
(en)
Reply to the" Comments on the article'Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations'", by Avogaro (Journal of Diabetes and Its Complications 25 [2011] 352-353)